Year Established :
1973
Total Number of Staff :
more than 1000
Main Competitive Advantages :
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages :
1) US FDA Approved facilities.
2) Controlled Substances
Business Type :
Manufacturer
R&D Capacity :
OEM,ODM,Own Brand
Main Sales Markets :
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Product Range :
Commercial API:
01) Amlodipine Benzoate
02) Amlodipine Besylate
03) Apremilast
04) Aripiprazole
05) Azilsartan Kamedoxomil
06) Bempedoic Acid
07) Cannabidiol
08) Dabigatran Etexilate Mesylate
09) Dalfampridine
10) Dimethyl Fumarate
11) Dronedarone
12) Duloxetine Hydrochloride
13) Eluxadoline
14) Esomeprazole Magnesium Trihydrate
15) Lanthanum Carbonate Octahydrate
16) Lurasidone Hydrochloride
17) Mesalamine
18) Nebivolol Hydrochloride
19) Olanzapine
20) Quetiapine Fumarate
21) Rasagiline Mesylate
22) Riluzole
23) Rizatriptan Benzoate
24) Sodium Oxybate
25) Solriamfetol Hydrochloride
26) Tolvaptan
Upcoming API's
01) Azilsartan
02) Eslicarbazepine
03) Ezetimibe
04) Hydrochlorothiazide
05) Rabeprazole Sodium
Under Development API's
01) Apixaban
02) Bupropion Hydrochloride
03) Candesartan
04) Dapaglifozin
05) Edoxaban Tosylate
06) Empagliflozin
07) Isavuconazonium Sulfate
08) Ivacaftor
09) Lercanidipine Hydrochloride
10) Minoxidil
11) Olmesartan Medoxomil
12) Sitagliptin Phosphate
13) Solifenacin Succinate